These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging. Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145 [TBL] [Abstract][Full Text] [Related]
25. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease. Pereira JB; Janelidze S; Ossenkoppele R; Kvartsberg H; Brinkmalm A; Mattsson-Carlgren N; Stomrud E; Smith R; Zetterberg H; Blennow K; Hansson O Brain; 2021 Feb; 144(1):310-324. PubMed ID: 33279949 [TBL] [Abstract][Full Text] [Related]
26. The associations between synaptic density and "A/T/N" biomarkers in Alzheimer's disease: An Li J; Huang Q; Qi N; He K; Li S; Huang L; Pan F; Ren S; Hua F; Huang Y; Guan Y; Guo Q; Zhao J; Xie F J Cereb Blood Flow Metab; 2024 Jul; 44(7):1199-1207. PubMed ID: 38295871 [TBL] [Abstract][Full Text] [Related]
27. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease. Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812 [TBL] [Abstract][Full Text] [Related]
34. Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer's disease and track disease progression and cognitive decline. Koss DJ; Jones G; Cranston A; Gardner H; Kanaan NM; Platt B Acta Neuropathol; 2016 Dec; 132(6):875-895. PubMed ID: 27770234 [TBL] [Abstract][Full Text] [Related]
35. Correlation between Cerebrospinal Fluid Core Alzheimer's Disease Biomarkers and β-Amyloid PET in Chinese Dementia Population. Xie Q; Ni M; Gao F; Dai LB; Lv XY; Zhang YF; Shi Q; Zhu XX; Xie JK; Shen Y; Wang SC ACS Chem Neurosci; 2022 May; 13(10):1558-1565. PubMed ID: 35476397 [TBL] [Abstract][Full Text] [Related]
36. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. Fleisher AS; Pontecorvo MJ; Devous MD; Lu M; Arora AK; Truocchio SP; Aldea P; Flitter M; Locascio T; Devine M; Siderowf A; Beach TG; Montine TJ; Serrano GE; Curtis C; Perrin A; Salloway S; Daniel M; Wellman C; Joshi AD; Irwin DJ; Lowe VJ; Seeley WW; Ikonomovic MD; Masdeu JC; Kennedy I; Harris T; Navitsky M; Southekal S; Mintun MA; JAMA Neurol; 2020 Jul; 77(7):829-839. PubMed ID: 32338734 [TBL] [Abstract][Full Text] [Related]
37. Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease. Takahashi RH; Nagao T; Gouras GK Pathol Int; 2017 Apr; 67(4):185-193. PubMed ID: 28261941 [TBL] [Abstract][Full Text] [Related]
38. Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment. Babić Leko M; Borovečki F; Dejanović N; Hof PR; Šimić G J Alzheimers Dis; 2016; 50(3):765-78. PubMed ID: 26836160 [TBL] [Abstract][Full Text] [Related]
39. Change in Cerebrospinal Fluid Tau Microtubule Binding Region Detects Symptom Onset, Cognitive Decline, Tangles, and Atrophy in Dominantly Inherited Alzheimer's Disease. Horie K; Li Y; Barthélemy NR; Gordon B; Hassenstab J; Benzinger TLS; Fagan AM; Morris JC; Karch CM; Xiong C; Allegri R; Mendez PC; Ikeuchi T; Kasuga K; Noble J; Farlow M; Chhatwal J; Day G; Schofield PR; Masters CL; Levin J; Jucker M; Lee JH; Roh JH; Sato C; Sachdev P; Koyama A; Reyderman L; Bateman RJ; McDade E; Ann Neurol; 2023 Jun; 93(6):1158-1172. PubMed ID: 36843330 [TBL] [Abstract][Full Text] [Related]